Resectable Pancreatic Cancer Needs Surgery, Then Chemotherapy

BMJ
doi 10.1136/bmj.328.7441.661-a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Meta-Analysis Comparing Upfront Surgery With Neoadjuvant Treatment in Patients With Resectable or Borderline Resectable Pancreatic Cancer

British Journal of Surgery
Surgery
2018English

A Pilot Study- Neoadjuvant Chemotherapy With Gemcitabine and S1 in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Journal of Carcinogenesis & Mutagenesis
2013English

Management of Borderline Resectable Pancreatic Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Clinicodemographic Aspect of Resectable Pancreatic Cancer and Prognostic Factors for Resectable Cancer

World Journal of Surgical Oncology
SurgeryOncology
2012English

Pancreatic Cancer Is ‘Always Non-Resectable’

Digestive Diseases
MedicineGastroenterology
2007English

Neoadjuvant Chemotherapy of Resectable Advanced Gastric Cancer

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
2012English

Sustained CA19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival

Oncologist
Cancer ResearchMedicineOncology
2020English

Erratum To: Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival

Annals of Surgical Oncology
OncologySurgery
2014English

Improving Outcomes in Patients With Resectable Pancreatic Cancer

British Journal of Surgery
Surgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy